Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues: |
| Treatment | 33.4 | 33.0 | 30.1 | 40.4 | 36.3 | | 32.3 | 41.3 |
| Services | 37.2 | 39.2 | 75.3 | 33.1 | 13.3 | | 19.0 | 21.1 |
| Total revenues | 70.6 | 72.2 | 105.4 | 73.5 | 49.5 | 49.8 | 51.2 | 62.4 |
| Revenue growth [+] | -2.2% | -31.5% | 43.5% | 48.3% | -0.5% | -2.8% | -17.9% | 9.3% |
| Treatment | 1.1% | 9.5% | -25.3% | 11.3% | | | -21.9% | -2.4% |
| Services | -5.0% | -47.9% | 127.5% | 149.4% | | | -10.0% | 43.1% |
| Cost of goods sold | 61.0 | 65.4 | 89.5 | 57.9 | 41.1 | 41.1 | 44.1 | 48.0 |
| Gross profit | 9.6 | 6.8 | 15.9 | 15.6 | 8.5 | 8.6 | 7.1 | 14.4 |
| Gross margin | 13.6% | 9.5% | 15.1% | 21.2% | 17.1% | 17.3% | 13.8% | 23.0% |
| Selling, general and administrative | 14.7 | 12.8 | 11.8 | 11.9 | 10.7 | 11.1 | 10.7 | 11.0 |
| Research and development | 0.3 | 0.7 | 0.8 | 0.8 | 1.4 | 1.6 | 2.0 | 2.3 |
| Other operating expenses | 0.0 | 1.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.1 |
| EBITDA [+] | -3.3 | -6.1 | 4.9 | 4.3 | -2.1 | -0.3 | -1.5 | 4.9 |
| EBITDA growth | -46.5% | -224.8% | 14.2% | -300.6% | 723.4% | -82.9% | -131.4% | 69.6% |
| EBITDA margin | -4.7% | -8.5% | 4.7% | 5.9% | -4.3% | -0.5% | -3.0% | 7.8% |
| Depreciation | 1.9 | 1.5 | 1.4 | 1.3 | 1.4 | 3.7 | 4.1 | 3.2 |
| EBITA | -5.2 | -7.6 | 3.6 | 3.0 | -3.5 | -4.0 | -5.6 | 1.6 |
| EBITA margin | -7.3% | -10.6% | 3.4% | 4.1% | -7.2% | -8.1% | -11.0% | 2.6% |
| Amortization of intangibles | 0.2 | 0.2 | 0.2 | 0.0 | 0.1 | 0.1 | 0.1 | 0.5 |
| EBIT [+] | -5.4 | -7.8 | 3.3 | 3.0 | -3.6 | -4.1 | -5.7 | 1.1 |
| EBIT growth | -31.1% | -335.3% | 12.1% | -182.4% | -11.3% | -28.6% | -602.0% | -182.1% |
| EBIT margin | -7.6% | -10.8% | 3.2% | 4.0% | -7.3% | -8.2% | -11.1% | 1.8% |
| Non-recurring items [+] | | -1.1 | | | | 0.7 | 10.1 | |
| Asset impairment | | | | | | 0.7 | 10.1 | |
| Interest expense, net [+] | 0.0 | 0.0 | 0.2 | 0.1 | 0.0 | 0.2 | 0.4 | 0.4 |
| Interest expense | 0.1 | 0.0 | 0.3 | 0.4 | 0.3 | 0.3 | 0.5 | 0.5 |
| Interest income | 0.1 | 0.0 | 0.1 | 0.3 | 0.3 | 0.1 | 0.1 | 0.1 |
| Other income (expense), net [+] | 1.8 | 4.0 | -0.2 | 0.0 | 1.6 | 0.1 | -0.1 | -0.2 |
| Gain (loss) on sale of assets | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.1 |
| Gain (loss) on debt retirement | | 5.4 | 0.0 | | | | | |
| Other | 1.9 | -0.1 | 0.2 | 0.2 | 0.0 | 0.1 | 0.0 | 0.0 |
| Pre-tax income | -3.6 | -2.8 | 3.0 | 2.9 | -2.0 | -4.8 | -16.3 | 0.5 |
| Income taxes | -0.4 | -3.9 | -0.2 | 0.2 | -0.9 | -1.3 | -3.0 | 0.5 |
| Tax rate | 10.5% | 139.0% | | 5.4% | 46.6% | 26.6% | 18.4% | 113.1% |
| Minority interest | | -0.2 | -0.1 | -0.1 | -0.3 | -0.5 | -0.6 | -0.9 |
| Net income | -3.8 | 1.9 | 6.0 | 5.0 | -1.4 | -3.7 | -13.4 | -1.1 |
| Net margin | -5.4% | 2.7% | 5.7% | 6.9% | -2.9% | -7.4% | -26.2% | -1.7% |
| |
| Basic EPS [+] | ($0.29) | $0.15 | $495.02 | $0.42 | ($0.12) | ($0.31) | ($1.15) | ($0.09) |
| Growth | -285.4% | -100.0% | 118048.7% | -449.5% | -61.9% | -72.8% | 1166.5% | -75.3% |
| Diluted EPS [+] | ($0.29) | $0.15 | $0.49 | $0.42 | ($0.12) | ($0.31) | ($1.15) | ($0.09) |
| Growth | -289.0% | -68.8% | 16.3% | -449.1% | -61.9% | -72.8% | 1170.5% | -75.3% |
| |
| Shares outstanding (basic) [+] | 13.3 | 12.4 | 0.0 | 12.0 | 11.9 | 11.7 | 11.6 | 11.5 |
| Growth | 6.8% | 102321.9% | -99.9% | 1.6% | 1.3% | 0.8% | 0.8% | 0.6% |
| Shares outstanding (diluted) [+] | 13.3 | 12.7 | 12.3 | 12.1 | 11.9 | 11.7 | 11.6 | 11.6 |
| Growth | 4.8% | 2.6% | 2.4% | 1.7% | 1.3% | 0.8% | 0.5% | 1.0% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|